Search: (WFRF:(Heneka Michael))
> (2015-2019) >
Targeting Neuroinfl...
Targeting Neuroinflammation to Treat Alzheimer’s Disease
-
- Ardura-Fabregat, A. (author)
- Albert-Ludwigs University Freiburg
-
- Boddeke, E. W.G.M. (author)
- University Medical Center Groningen
-
- Boza-Serrano, A. (author)
- Lund University,Lunds universitet,Neuroinflammation,Forskargrupper vid Lunds universitet,Lund University Research Groups
-
show more...
-
- Brioschi, S. (author)
- Albert-Ludwigs University Freiburg
-
- Castro-Gomez, S. (author)
- University Hospital Bonn
-
- Ceyzériat, K. (author)
- CEA Dam Ile-de France (DIF),University of Paris-Saclay
-
- Dansokho, C. (author)
- German Center for Neurodegenerative Diseases (DZNE), Bonn
-
- Dierkes, T. (author)
- University Hospital Bonn,German Center for Neurodegenerative Diseases (DZNE), Bonn
-
- Gelders, G. (author)
- Catholic University of Leuven
-
- Heneka, Michael T. (author)
- University Hospital Bonn,German Center for Neurodegenerative Diseases (DZNE), Bonn
-
- Hoeijmakers, L. (author)
- University of Amsterdam
-
- Hoffmann, A. (author)
- University Hospital Erlangen
-
- Iaccarino, L. (author)
- Vita-Salute San Raffaele University,San Raffaele Scientific Institute
-
- Jahnert, S. (author)
- University Hospital Bonn
-
- Kuhbandner, K. (author)
- University Hospital Erlangen
-
- Landreth, G. (author)
- Indiana University
-
- Lonnemann, N. (author)
- Technical University of Braunschweig
-
- Löschmann, P. A. (author)
- Pfizer Inc. US
-
- McManus, R. M. (author)
- German Center for Neurodegenerative Diseases (DZNE), Bonn
-
- Paulus, A. (author)
- Lund University,Lunds universitet,Neuroinflammation,Forskargrupper vid Lunds universitet,Lund University Research Groups
-
- Reemst, K. (author)
- University of Amsterdam
-
- Sanchez-Caro, J. M. (author)
- German Center for Neurodegenerative Diseases (DZNE), Bonn
-
- Tiberi, A. (author)
- Scuola Normale Superiore di Pisa
-
- van der Perren, A. (author)
- Catholic University of Leuven
-
- Vautheny, A. (author)
- CEA Dam Ile-de France (DIF),University of Paris-Saclay
-
- Venegas, C. (author)
- University Hospital Bonn
-
- Webers, A. (author)
- University Hospital Bonn
-
- Weydt, P. (author)
- University Hospital Bonn
-
- Wijasa, T. S. (author)
- German Center for Neurodegenerative Diseases (DZNE), Bonn
-
- Xiang, X. (author)
- World Orthopaedic Concern
-
- Yang, Y. (author)
- Lund University,Lunds universitet,Proteinbioinformatik,Forskargrupper vid Lunds universitet,Protein Bioinformatics,Lund University Research Groups
-
show less...
-
(creator_code:org_t)
- 2017-12-19
- 2017
- English 26 s.
-
In: CNS Drugs. - : Springer Science and Business Media LLC. - 1172-7047 .- 1179-1934. ; 31:12, s. 1-26
- Related links:
-
http://dx.doi.org/10... (free)
-
show more...
-
https://link.springe...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Over the past few decades, research on Alzheimer’s disease (AD) has focused on pathomechanisms linked to two of the major pathological hallmarks of extracellular deposition of beta-amyloid peptides and intra-neuronal formation of neurofibrils. Recently, a third disease component, the neuroinflammatory reaction mediated by cerebral innate immune cells, has entered the spotlight, prompted by findings from genetic, pre-clinical, and clinical studies. Various proteins that arise during neurodegeneration, including beta-amyloid, tau, heat shock proteins, and chromogranin, among others, act as danger-associated molecular patterns, that—upon engagement of pattern recognition receptors—induce inflammatory signaling pathways and ultimately lead to the production and release of immune mediators. These may have beneficial effects but ultimately compromise neuronal function and cause cell death. The current review, assembled by participants of the Chiclana Summer School on Neuroinflammation 2016, provides an overview of our current understanding of AD-related immune processes. We describe the principal cellular and molecular players in inflammation as they pertain to AD, examine modifying factors, and discuss potential future therapeutic targets.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Publication and Content Type
- for (subject category)
- ref (subject category)
Find in a library
-
CNS Drugs
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Ardura-Fabregat, ...
-
Boddeke, E. W.G. ...
-
Boza-Serrano, A.
-
Brioschi, S.
-
Castro-Gomez, S.
-
Ceyzériat, K.
-
show more...
-
Dansokho, C.
-
Dierkes, T.
-
Gelders, G.
-
Heneka, Michael ...
-
Hoeijmakers, L.
-
Hoffmann, A.
-
Iaccarino, L.
-
Jahnert, S.
-
Kuhbandner, K.
-
Landreth, G.
-
Lonnemann, N.
-
Löschmann, P. A.
-
McManus, R. M.
-
Paulus, A.
-
Reemst, K.
-
Sanchez-Caro, J. ...
-
Tiberi, A.
-
van der Perren, ...
-
Vautheny, A.
-
Venegas, C.
-
Webers, A.
-
Weydt, P.
-
Wijasa, T. S.
-
Xiang, X.
-
Yang, Y.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Neurosciences
- Articles in the publication
-
CNS Drugs
- By the university
-
Lund University